The membership of ENIGMA is listed in Supp. Table S1.
ENIGMA—Evidence-based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes†
Version of Record online: 3 NOV 2011
© 2011 Wiley Periodicals, Inc.
Volume 33, Issue 1, pages 2–7, January 2012
How to Cite
Spurdle, A. B., Healey, S., Devereau, A., Hogervorst, F. B. L., Monteiro, A. N. A., Nathanson, K. L., Radice, P., Stoppa-Lyonnet, D., Tavtigian, S., Wappenschmidt, B., Couch, F. J., Goldgar, D. E. and on behalf of ENIGMA (2012), ENIGMA—Evidence-based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. Hum. Mutat., 33: 2–7. doi: 10.1002/humu.21628
Communicated by Richard G. H. Cotton
- Issue online: 14 DEC 2011
- Version of Record online: 3 NOV 2011
- Accepted manuscript online: 11 OCT 2011 01:34PM EST
- Manuscript Accepted: 26 SEP 2011
- Manuscript Received: 21 APR 2011
- NHMRC (Senior Research Fellowship to A.B.S.)
- NIH (CA148112 and CA116167 to A.N.A.M.)
- Breast Cancer Research Foundation (to K.L.N.)
- Italian Association for Cancer Research (A.I.R.C. to P.R.)
- German Cancer Aid (grant 107364 to B.W.)
- Centre of Molecular Medicine Cologne (to B.W.)
- NIH (grant CA116167 to F.J.C. and D.E.G.)
- NIH Recovery Act supplement (CA116167Z to F.J.C.)
- NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201 to F.J.C.)
Additional Supporting information may be found in the online version of this article
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.